Angharad Davis

1.4k total citations
24 papers, 594 citations indexed

About

Angharad Davis is a scholar working on Surgery, Infectious Diseases and Microbiology. According to data from OpenAlex, Angharad Davis has authored 24 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Infectious Diseases and 6 papers in Microbiology. Recurrent topics in Angharad Davis's work include Infectious Diseases and Tuberculosis (10 papers), Tuberculosis Research and Epidemiology (6 papers) and Bacterial Infections and Vaccines (6 papers). Angharad Davis is often cited by papers focused on Infectious Diseases and Tuberculosis (10 papers), Tuberculosis Research and Epidemiology (6 papers) and Bacterial Infections and Vaccines (6 papers). Angharad Davis collaborates with scholars based in United Kingdom, South Africa and United States. Angharad Davis's co-authors include Gavin Giovannoni, Ruth Dobson, S V Ramagopalan, Robert J. Wilkinson, Patrick Haggard, Corinne Jola, Graeme Meintjes, Klaus Schmierer, Sharmilee Gnanapavan and Mónica Marta and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Angharad Davis

22 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angharad Davis United Kingdom 10 313 191 108 98 88 24 594
Hans Wolfgang Kölmel Germany 15 230 0.7× 101 0.5× 68 0.6× 78 0.8× 99 1.1× 41 812
Jae Yong Byun South Korea 20 192 0.6× 424 2.2× 255 2.4× 41 0.4× 56 0.6× 103 1.1k
Robert Bühler Switzerland 12 144 0.5× 241 1.3× 57 0.5× 25 0.3× 24 0.3× 15 684
Paulo Eurípedes Marchiori Brazil 15 155 0.5× 266 1.4× 72 0.7× 69 0.7× 32 0.4× 61 575
M Netravathi India 17 108 0.3× 468 2.5× 47 0.4× 48 0.5× 155 1.8× 112 868
A. V. Ciurea Romania 14 184 0.6× 168 0.9× 193 1.8× 22 0.2× 21 0.2× 54 686
Giuseppe Attanasio Italy 20 86 0.3× 285 1.5× 63 0.6× 108 1.1× 23 0.3× 60 1.1k
John Dutton United States 16 80 0.3× 144 0.8× 288 2.7× 44 0.4× 47 0.5× 28 791
Winnie Pao United States 9 157 0.5× 245 1.3× 35 0.3× 57 0.6× 53 0.6× 9 862
Eiji Kitamura Japan 14 50 0.2× 235 1.2× 57 0.5× 25 0.3× 73 0.8× 50 597

Countries citing papers authored by Angharad Davis

Since Specialization
Citations

This map shows the geographic impact of Angharad Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angharad Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angharad Davis more than expected).

Fields of papers citing papers by Angharad Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angharad Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angharad Davis. The network helps show where Angharad Davis may publish in the future.

Co-authorship network of co-authors of Angharad Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Angharad Davis. A scholar is included among the top collaborators of Angharad Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angharad Davis. Angharad Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wasserman, Sean, Angharad Davis, Cari Stek, et al.. (2025). Population pharmacokinetics of pyrazinamide and isoniazid in plasma and cerebrospinal fluid from South African adults with tuberculous meningitis. Antimicrobial Agents and Chemotherapy. 69(8). e0009925–e0009925. 1 indexed citations
2.
Wasserman, Sean, Angharad Davis, Cari Stek, et al.. (2025). Population Pharmacokinetics of Rifampicin in Plasma and Cerebrospinal Fluid in Adults With Tuberculosis Meningitis. The Journal of Infectious Diseases. 232(2). e234–e241. 1 indexed citations
3.
Barnacle, James, Angharad Davis, & Robert J. Wilkinson. (2024). Recent advances in understanding the human host immune response in tuberculous meningitis. Frontiers in Immunology. 14. 1326651–1326651. 11 indexed citations
4.
Wasserman, Sean, Angharad Davis, Cari Stek, et al.. (2023). Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis. The Journal of Infectious Diseases. 229(4). 1200–1208. 9 indexed citations
5.
Jackson, Amanda, Jon Ambler, Elsa Du Bruyn, et al.. (2021). TBDBT: A TB DataBase Template for collection of harmonized TB clinical research data in REDCap, facilitating data standardisation for inter-study comparison and meta-analyses. PLoS ONE. 16(3). e0249165–e0249165. 2 indexed citations
6.
Davis, Angharad & Robert J. Wilkinson. (2021). Aspirin in tuberculous meningitis. EClinicalMedicine. 35. 100871–100871. 1 indexed citations
7.
Davis, Angharad & Robert J. Wilkinson. (2020). Diagnostic tests for tuberculous meningitis. The Lancet Infectious Diseases. 20(3). 262–263. 11 indexed citations
8.
Davis, Angharad, Graeme Meintjes, & Robert J. Wilkinson. (2018). Treatment of Tuberculous Meningitis and Its Complications in Adults. Current Treatment Options in Neurology. 20(3). 5–5. 54 indexed citations
9.
Giovannoni, Gavin, Mónica Marta, Angharad Davis, et al.. (2016). Switching patients at high risk of PML from natalizumab to another disease-modifying therapy. Practical Neurology. 16(5). 389–393. 41 indexed citations
10.
Davis, Angharad, et al.. (2015). Curious turns in the night-time. Practical Neurology. 15(5). 389–392.
11.
Davis, Angharad, et al.. (2015). Atraumatic needles for lumbar puncture: why haven't neurologists changed?. Practical Neurology. 16(1). 18–22. 8 indexed citations
12.
Davis, Angharad, et al.. (2013). Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. European Journal of Neurology. 21(2). 305–311. 27 indexed citations
13.
Dobson, Ruth, S V Ramagopalan, Angharad Davis, & Gavin Giovannoni. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. Journal of Neurology Neurosurgery & Psychiatry. 84(8). 909–914. 269 indexed citations
14.
Davis, Angharad, et al.. (2013). HEAVY METAL TOXICITY: LESSONS FROM A CASE OF SIMULTANEOUS OCCUPATIONAL EXPOSURE TO MANGANESE AND MERCURY. Journal of Neurology Neurosurgery & Psychiatry. 84(11). e2.31–e2. 6 indexed citations
15.
Dobson, Ruth, J. Topping, Angharad Davis, E J Thompson, & Gavin Giovannoni. (2013). Cerebrospinal fluid and urinary biomarkers in multiple sclerosis. Acta Neurologica Scandinavica. 128(5). n/a–n/a. 18 indexed citations
16.
Dobson, Ruth, Maria Thom, Angharad Davis, et al.. (2013). THINK OUTSIDE THE BOX, COLLAPSE THE BOX, AND TAKE A SHARP KNIFE TO IT!. Journal of Neurology Neurosurgery & Psychiatry. 84(11). e2.83–e2. 1 indexed citations
17.
Jola, Corinne, Angharad Davis, & Patrick Haggard. (2011). Proprioceptive integration and body representation: insights into dancers’ expertise. Experimental Brain Research. 213(2-3). 257–265. 68 indexed citations
18.
Davis, Angharad, D. W. T. Crompton, M. C. Nesheim, & Z. Pawłowski. (1985). Ascariasis: drugs and drug policy.. 239–244. 5 indexed citations
19.
Davis, Angharad, et al.. (1965). RESINATES OF LUCANTHONE IN THE TREATMENT OF SCHISTOSOMIASIS.. PubMed. 42. 10–30. 3 indexed citations
20.
Davis, Angharad. (1963). ATTEMPTED SUPPRESSION OF ENDEMIC URINARY BILHARZIASIS WITH THIOXANTHONES.. PubMed. 40. 628–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026